{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:15:09Z","timestamp":1791306909673,"version":"4.3.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.05.023","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T21:24:56Z","timestamp":1432329896000},"page":"3288-3292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Deaths following vaccination: What does the evidence show?"],"prefix":"10.1016","volume":"33","author":[{"given":"Elaine R.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5912-7415","authenticated-orcid":false,"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2015.05.023_bib0350","first-page":"243","article-title":"Achievements in public health, 1900\u20131999 impact of vaccines universally recommended for children \u2013 United States, 1990\u20131998","volume":"48","author":"Centers for Disease Control and Prevention (CDC)","year":"1999","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0355","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","article-title":"Addressing the vaccine confidence gap","volume":"378","author":"Larson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0360","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/hv.27243","article-title":"Epidemiology of vaccine hesitancy in the United States","volume":"9","author":"Siddiqui","year":"2013","journal-title":"Hum Vaccine Immunother"},{"issue":"14","key":"10.1016\/j.vaccine.2015.05.023_bib0365","first-page":"373","article-title":"Measles-United States, January 4\u2013April 2, 2015","volume":"64","author":"Clemmons","year":"2015","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0370","unstructured":"Shilhavy B. Zero US measles deaths in 10 years, but over 100 measles vaccine deaths reported. Health Impact News February 12, 2015. Available at: http:\/\/healthimpactnews.com\/\/zero-u-s-measles-deaths-in-10-years-but-over-100-measles-vaccine-deaths-reported\/ [accessed 12.02.15]."},{"key":"10.1016\/j.vaccine.2015.05.023_bib0375","unstructured":"Huff EA. Measles vaccines kill more people than measles, CDC data proves. Global Research February 5, 2015. Available at: http:\/\/www.globalresearch.ca\/measles-vaccines-kill-more-people-than-measles-cdc-data-proves\/5429736 [accessed 12.02.15]."},{"key":"10.1016\/j.vaccine.2015.05.023_bib0380","unstructured":"Wofford T.A. Look at Anti-Vaxxers\u2019 Monstrously Bad Measles Math. Newsweek February 3, 2015. Available at: http:\/\/www.newsweek.com\/look-anti-vaxxers-monstrously-bad-measles-math-304078 [accessed 12.02.15]."},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0390","unstructured":"World Health Organization. Statement regarding interim findings of WHO assessment of deaths of children in Idleb Governorate, Syria, 27 September 2014. Available at: http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/interim-findings-idleb-syria\/en\/ [accessed 12.02.15]."},{"key":"10.1016\/j.vaccine.2015.05.023_bib0395","unstructured":"World Health Organization. Information for health-care workers-managing adverse events; 9 April 2009. Available at: http:\/\/www.who.int\/vaccine_safety\/initiative\/detection\/managing_AEFIs\/en\/index4.html [accessed 12.02.15]."},{"issue":"14","key":"10.1016\/j.vaccine.2015.05.023_bib0400","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMp048180","article-title":"The Cutter incident, 50 years later","volume":"352","author":"Offit","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0405","first-page":"29","article-title":"The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0410","series-title":"The Cutter Incident: how America's first polio vaccine led to the growing vaccine crisis","author":"Offit","year":"2005"},{"issue":"8","key":"10.1016\/j.vaccine.2015.05.023_bib0415","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3928\/00904481-20130723-08","article-title":"Vaccines in the pipeline: the path from development to use in the United States","volume":"42","author":"Pickering","year":"2013","journal-title":"Pediatr Ann"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.05.023_bib0420","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1542\/peds.2010-1722E","article-title":"Food and Drug Administration regulation and evaluation of vaccines","volume":"127","author":"Marshall","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.023_bib0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1201.051007","article-title":"Reflections on the 1976 swine flu vaccination program","volume":"12","author":"Sencer","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.023_bib0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0435","series-title":"The vaccine controversy: the history, use and safety of vaccinations","author":"Link","year":"2005"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0440","series-title":"Adverse events associated with childhood vaccines: evidence bearing on causality","author":"Institute of Medicine","year":"1994"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0445","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.619","article-title":"The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990\u20131997","volume":"10","author":"Silvers","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"15","key":"10.1016\/j.vaccine.2015.05.023_bib0450","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0455","article-title":"Post-licensure surveillance of trivalent live-attenuated influenza vaccine in children aged 2\u201318 years, Vaccine Adverse Event Reporting System, United States, July 2005\u2013June 2012","author":"Haber","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"7","key":"10.1016\/j.vaccine.2015.05.023_bib0460","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.12.014","article-title":"Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990\u20132013","author":"Moro","year":"2015","journal-title":"J Pediatr"},{"issue":"48","key":"10.1016\/j.vaccine.2015.05.023_bib0470","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1016\/j.vaccine.2014.09.018","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005\u2013June 2013","volume":"32","author":"Haber","year":"2014","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2015.05.023_bib0475","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1016\/j.vaccine.2011.05.100","article-title":"Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005\u20132010","volume":"29","author":"Moro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0480","series-title":"Immunization safety review: vaccinations and sudden unexpected death in infancy","author":"Institute of Medicine","year":"2003"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.023_bib0485","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amepre.2013.02.020","article-title":"Mortality rates and cause-of-death patterns in a vaccinated population","volume":"45","author":"McCarthy","year":"2013","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0490","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.023_bib0495","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.anai.2011.01.014","article-title":"Analysis of anaphylaxis cases after vaccination: 10-year review from the National Vaccine Injury Compensation Program","volume":"106","author":"Johann-Liang","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"RR02","key":"10.1016\/j.vaccine.2015.05.023_bib0500","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices","volume":"60","author":"Kroger","year":"2011","journal-title":"MMWR"},{"issue":"9568","key":"10.1016\/j.vaccine.2015.05.023_bib0505","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.023_bib0510","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4161\/hv.26200","article-title":"Fatal varicella due to the vaccine-strain varicella-zoster virus","volume":"10","author":"Leung","year":"2014","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0515","series-title":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. The Pink Book","article-title":"Measles chapter","year":"2012"},{"issue":"28","key":"10.1016\/j.vaccine.2015.05.023_bib0520","first-page":"603","article-title":"Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0525","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/520449","article-title":"Measles inclusion-body encephalitis caused by the vaccine strain of measles virus","volume":"29","author":"Bitnun","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.023_bib0530","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2011.08.012","article-title":"Trends in intussusception-associated deaths among US infants from 1979\u20132007","volume":"160","author":"Desai","year":"2012","journal-title":"J Pediatr"},{"issue":"34","key":"10.1016\/j.vaccine.2015.05.023_bib0535","first-page":"786","article-title":"Suspension of rotavirus vaccine after reports of intussusception\u2014United States, 1999","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR"},{"issue":"8","key":"10.1016\/j.vaccine.2015.05.023_bib0540","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.023_bib0545","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1542\/peds.107.6.e97","article-title":"Intussusception among recipients of rotavirus vaccine: reports to the Vaccine Adverse Event Reporting System","volume":"107","author":"Zanardi","year":"2001","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.023_bib0550","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.023_bib0555","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.023_bib0560","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.023_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e318270362c","article-title":"Potential intussusception risk versus benefits of rotavirus vaccination in the United States","volume":"32","author":"Desai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.023_bib0570","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"Intussusception after rotavirus vaccines reported to US VAERS, 2006\u20132012","volume":"131","author":"Haber","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.023_bib0575","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2015.05.023_bib0580","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2015.05.023_bib0585","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain\u2013Barr\u00e9 syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9876","key":"10.1016\/j.vaccine.2015.05.023_bib0590","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain\u2013Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0595","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","article-title":"Cumulative risk of Guillain\u2013Barr\u00e9 syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic","volume":"104","author":"Vellozzi","year":"2014","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.023_bib0600","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000339248","article-title":"Guillain\u2013Barr\u00e9 syndrome incidence in a large United States cohort (2000\u20132009)","volume":"39","author":"Shui","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0605","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0610","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institute of Medicine","year":"2011"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.023_bib0615","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jwh.2011.2895","article-title":"Reported adverse events in young women following quadrivalent human papillomavirus vaccination","volume":"21","author":"Naleway","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.023_bib0620","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archpedi.159.11.1083","article-title":"Fatal syncope-related fall after immunization","volume":"159","author":"Woo","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.023_bib0625","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archpedi.1997.02170400041007","article-title":"Syncope after immunization","volume":"151","author":"Braun","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0630","series-title":"The Yellow Book. CDC Health Information for International Travel 2014. US Dept. of Health and Human Services. Centers for Disease Control and Prevention","article-title":"Yellow fever chapter","author":"Gershman","year":"2014"},{"issue":"RR07","key":"10.1016\/j.vaccine.2015.05.023_bib0635","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR"},{"issue":"RR01","key":"10.1016\/j.vaccine.2015.05.023_bib0640","first-page":"1","article-title":"Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions","volume":"55","author":"Casey","year":"2006","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0645","unstructured":"ACAM2000 (Smallpox) Sanofi Pasteur Biologics Co. package insert. Available at http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm180810.htm [accessed 04.05.15]."},{"key":"10.1016\/j.vaccine.2015.05.023_bib0650","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Dev Ther"},{"issue":"RR02","key":"10.1016\/j.vaccine.2015.05.023_bib0655","first-page":"1","article-title":"Clinical guidance for smallpox vaccine use in a postevent vaccination program","volume":"64","author":"Petersen","year":"2015","journal-title":"MMWR"},{"issue":"RR07","key":"10.1016\/j.vaccine.2015.05.023_bib0660","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0665","series-title":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. The Pink Book","article-title":"Poliomyelitis chapter","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.05.023_bib0670","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"issue":"RR-5","key":"10.1016\/j.vaccine.2015.05.023_bib0675","first-page":"1","article-title":"Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Prevots","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0680","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.023_bib0685","first-page":"52252","article-title":"21 CFR Part 600.80. Postmarketing reporting of adverse experiences","volume":"62","author":"Food and Drug Administration","year":"1997","journal-title":"Fed Regist"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.023_bib0690","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:40Z","timestamp":1759400560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":69,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15006556"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deaths following vaccination: What does the evidence show?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}